FPIN's Clinical Inquiries

Self-Administered GBS Testing in Pregnant Women

 


FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access.


FREE PREVIEW. Purchase online access to read the full version of this article.

Am Fam Physician. 2014 Nov 15;90(10):729-730.

Clinical Question

How sensitive and acceptable is self-administered testing for group B streptococcus (GBS) in pregnant women?

Evidence-Based Answer

There is no difference in the sensitivity of swabs for detecting GBS when collected by patients vs. physicians; therefore, either method can be used. (Strength of Recommendation: C, based on cohort and randomized studies.) Patients do not express a consistent preference for self-collection of samples vs. collection by a physician.

Evidence Summary

Four trials compared self- and physician-collected swabs to detect GBS in pregnant patients.14 Each study recruited women at 35 to 37 weeks' gestation. The reference standard in each study was a positive GBS culture by either collection method. Agreement between the two methods was high. GBS prevalence ranged from 12% to 19%. In two of the four trials, cultures were not incubated in an enrichment broth, which may have resulted in a lower GBS prevalence.2,4

In a 2006 prospective trial, 330 women (average age = 27.2 years) at a family medicine prenatal care clinic in Canada were randomly assigned to clinician-collected vaginorectal swabs followed by self-collected swabs, or vice versa.1 The women received written instructions and a diagram of the self-collection procedure. Clinicians were not blinded to the testing sequence. Both collection methods yielded comparable sensitivity (97% clinician-collected vs. 87% self-collected; Cohen's kappa agreement = 0.9; 95% confidence interval [CI], 0.8 to 1). Patients were slightly more likely to prefer self-collection. There were 56 patients who declined to participate. Participants were four times more likely than nonparticipants to have completed high school (odds ratio [OR] = 4; 95% CI, 1.2 to 13.4), and those who declined were more likely to prefer collection by a clinician (OR = 6.9; 95% CI, 2.8 to 17.1).

A 2008 nonrandomized, prospective study of 600 women (average age = 31 years) compared self-collected GBS culture results with those obtained from a subsequent physician-collected sample.2 Patients were recruited from public and private prenatal clinics in Ireland, and clinic staff explained the self-collection procedure to the patients. As in the previous study, both collection methods had high sensitivity (94% clinician-collected vs. 84% self-collected; Cohen's kappa agreement = 0.9; 95% CI, 0.8 to 0.9). The women preferred collection by a physician over self-collection (43% vs. 28%; 28% reported no preference). The most common reason given was concern about collecting the sample correctly.

A 2000 nonrandomized, prospective study at a military hospital in Colorado alternately assigned 250 women to physician-collected swabs followed by self-collection, or vice versa.3 Patients received written instructions and a diagram of the self-collection procedure. There was no difference in first vs. second sample sensitivities in either group (93% clinician-collected vs. 84% self-collected; Cohen's kappa agreement = 0.8; 95% CI, 0.7 to 0.9). The women slightly preferred self-collection (58% vs. 42%).

A 2009 retrospective analysis compared GBS culture results from 293 patients who performed self-collection with those of 507 patients in whom physicians collected the samples.4 The patients attended two community clinics in Colorado; 75% were Hispanic and 85% were below 200% of the federal poverty level. GBS prevalence was slightly higher in the patient-collected samples (13% vs. 11% in clinician-collected samples), but the difference was not statistically significant. The patients did not receive uniform instructions for self-collection. The authors did not report patient preferences.

Recommendations from Others

The Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists recommend universal screening for GBS at 35 to 37 weeks' gestation with samples collected by the physician or, with appropriate instruction, by the patient.5,6

Author disclosure: No relevant financial affiliations.

Address correspondence to Hillary Mount, MD, at hillary.mount@thechristhospital.com. Reprints are not available from the authors.

REFERENCES

show all references

1. Price D, Shaw E, Howard M, Zazulak J, Waters H, Kaczorowski J. Self-sampling for group B streptococcus in women 35 to 37 weeks pregnant is accurate and acceptable: a randomized cross-over trial. J Obstet Gynaecol Can. 2006;28(12):1083–1088....

2. Arya A, Cryan B, O'Sullivan K, Greene RA, Higgins JR. Self-collected versus health professional-collected genital swabs to identify the prevalence of group B streptococcus: a comparison of patient preference and efficacy. Eur J Obstet Gynecol Reprod Biol. 2008;139(1):43–45.

3. Torok PG, Dunn JR. Self-collection of antepartum anogenital group B streptococcus cultures. J Am Board Fam Pract. 2000;13(2):107–110.

4. Hicks P, Diaz-Perez MJ. Patient self-collection of group B streptococcal specimens during pregnancy. J Am Board Fam Med. 2009;22(2):136–140.

5. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1–36.

6. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG committee opinion no. 485: prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2011;117(4):1019–1027.

Clinical Inquiries provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (http://www.cebm.net/?o=1025).

The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to http://www.fpin.org or e-mail: questions@fpin.org.

This series is coordinated by John E. Delzell, Jr., MD, MSPH, Assistant Medical Editor.

A collection of FPIN's Clinical Inquiries published in AFP is available at http://www.aafp.org/afp/fpin.



 

Want to use this article elsewhere? Get Permissions


More in AFP


Editor's Collections


Related Content


More in Pubmed

MOST RECENT ISSUE


Dec 1, 2016

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article